Directors‘ Dealings
Reportable transactions with financial instruments of the Company
Disclosures concerning own-account transactions by persons discharging managerial responsibilities pursuant to Section 19 Market Abuse Regulation (EU) No. 596/2014 (Managers' Transactions)
The members of the Supervisory Board and the Executive Board and other persons discharging managerial responsibilities who regularly have access to insider information on the Company and who are authorized to make significant business decisions, and certain persons who are in a close relationship to the aforementioned, are, pursuant to Section 19 of the Market Abuse Regulation (EU) No. 596/2014, legally obligated to report any own-account transactions with financial instruments of Bilfinger SE (shares, debt securities, associated derivatives or any other related financial instruments) in an amount exceeding EUR 20,000.00 in a calendar year to Bilfinger SE and the German Financial Supervision Authority (BaFin) immediately, at the latest within three business days following the date of the transaction. Bilfinger SE is obligated to publish these own-account transactions within two business days of receipt of the notification from the person required to report.
- Purchase Christina Johansson, 10.05.2019 [PDF, 7.9 KB]
- Allocation Tom Blades, 09.05.2019 [PDF, 7.7 KB]
- Allocation Michael Bernhardt, 09.05.2019 [PDF, 8.0 KB]
- Purchase Michael Bernhardt, 21.02.2019 [PDF, 8.2 KB]
- Purchase Christina Johansson, 14.02.2019 [PDF, 11.3 KB]
- Purchase Duncan Hall, 14.02.2019 [PDF, 7.5 KB]
- Purchase Tom Blades, 14.02.2019 [PDF, 8.7 KB]
- Purchase Duncan Hall, 11.01.2019 [PDF, 7.5 KB]
- Purchase Dr. Klaus Patzak, 14.12.2016 [PDF, 183.6 KB]
- Purchase Dr. Klaus Patzak, 12.12.2016 [PDF, 183.3 KB]
- Purchase Michael Bernhardt, 25.11.2016 [PDF, 183.3 KB]
- Purchase Tom Blades, 23.11.2016 [PDF, 184.7 KB]
- Purchase Dr. Klaus Patzak, 17.11.2016 [PDF, 183.8 KB]
- Purchase Tom Blades, 14.11.2016 [PDF, 184.8 KB]